简介内容:GST-HG131, a dihydrobenzopyridooxazepine (DBP) series compound, specifically inhibits hepatitis B virus (HBV) surface antigen. It demonstrates excellent HBV antigens inhibition, with EC50 values of nM (HBsAg) and nM (HBeAg), respectively, and is safe for animal use.